157 related articles for article (PubMed ID: 25400783)
21. The immune cell infiltrate populating meningiomas is composed of mature, antigen-experienced T and B cells.
Fang L; Lowther DE; Meizlish ML; Anderson RC; Bruce JN; Devine L; Huttner AJ; Kleinstein SH; Lee JY; Stern JN; Yaari G; Lovato L; Cronk KM; O'Connor KC
Neuro Oncol; 2013 Nov; 15(11):1479-90. PubMed ID: 23978377
[TBL] [Abstract][Full Text] [Related]
22. Tumor-infiltrating B cells and T cells correlate with postoperative prognosis in triple-negative carcinoma of the breast.
Kuroda H; Jamiyan T; Yamaguchi R; Kakumoto A; Abe A; Harada O; Masunaga A
BMC Cancer; 2021 Mar; 21(1):286. PubMed ID: 33726701
[TBL] [Abstract][Full Text] [Related]
23. A high CD8 to FOXP3 ratio in the tumor stroma and expression of PTEN in tumor cells are associated with improved survival in non-metastatic triple-negative breast carcinoma.
Tavares MC; Sampaio CD; Lima GE; Andrade VP; Gonçalves DG; Macedo MP; Cordeiro de Lima VC
BMC Cancer; 2021 Aug; 21(1):901. PubMed ID: 34362334
[TBL] [Abstract][Full Text] [Related]
24. Pathological significance and prognostic roles of densities of CD57+ cells, CD68+ cells, and mast cells, and their ratios in clear cell renal cell carcinoma.
Nakanishi H; Miyata Y; Mochizuki Y; Yasuda T; Nakamura Y; Araki K; Sagara Y; Matsuo T; Ohba K; Sakai H
Hum Pathol; 2018 Sep; 79():102-108. PubMed ID: 29787818
[TBL] [Abstract][Full Text] [Related]
25. Immune microenvironment in ductal carcinoma in situ: a comparison with invasive carcinoma of the breast.
Kim M; Chung YR; Kim HJ; Woo JW; Ahn S; Park SY
Breast Cancer Res; 2020 Mar; 22(1):32. PubMed ID: 32216826
[TBL] [Abstract][Full Text] [Related]
26. Prognostic value of tumor-infiltrating lymphocytes differs depending on histological type and smoking habit in completely resected non-small-cell lung cancer.
Kinoshita T; Muramatsu R; Fujita T; Nagumo H; Sakurai T; Noji S; Takahata E; Yaguchi T; Tsukamoto N; Kudo-Saito C; Hayashi Y; Kamiyama I; Ohtsuka T; Asamura H; Kawakami Y
Ann Oncol; 2016 Nov; 27(11):2117-2123. PubMed ID: 27502728
[TBL] [Abstract][Full Text] [Related]
27. Immune subtyping of extranodal NK/T-cell lymphoma: a new biomarker and an immune shift during disease progression.
Cho J; Kim SJ; Park WY; Kim J; Woo J; Kim G; Yoon SE; Ko YH; Kim WS
Mod Pathol; 2020 Apr; 33(4):603-615. PubMed ID: 31653980
[TBL] [Abstract][Full Text] [Related]
28. Expression and prognostic impact of immune modulatory molecule PD-L1 in meningioma.
Han SJ; Reis G; Kohanbash G; Shrivastav S; Magill ST; Molinaro AM; McDermott MW; Theodosopoulos PV; Aghi MK; Berger MS; Butowski NA; Barani I; Phillips JJ; Perry A; Okada H
J Neurooncol; 2016 Dec; 130(3):543-552. PubMed ID: 27624915
[TBL] [Abstract][Full Text] [Related]
29. The predictive value of CD8, CD4, CD68, and human leukocyte antigen-D-related cells in the prognosis of cutaneous malignant melanoma with vertical growth phase.
Piras F; Colombari R; Minerba L; Murtas D; Floris C; Maxia C; Corbu A; Perra MT; Sirigu P
Cancer; 2005 Sep; 104(6):1246-54. PubMed ID: 16078259
[TBL] [Abstract][Full Text] [Related]
30. Immunocyte density in parathyroid carcinoma is correlated with disease relapse.
Hu Y; Cui M; Bi Y; Zhang X; Wang M; Hua S; Liao Q; Zhao Y
J Endocrinol Invest; 2020 Oct; 43(10):1453-1461. PubMed ID: 32219691
[TBL] [Abstract][Full Text] [Related]
31. Tumor-infiltrating immune cell subpopulations influence the oncologic outcome after intravesical Bacillus Calmette-Guérin therapy in bladder cancer.
Pichler R; Fritz J; Zavadil C; Schäfer G; Culig Z; Brunner A
Oncotarget; 2016 Jun; 7(26):39916-39930. PubMed ID: 27221038
[TBL] [Abstract][Full Text] [Related]
32. CD11c+CD163+ Cells and Signal Transducer and Activator of Transcription 3 (STAT3) Expression Are Common in Melanoma Leptomeningeal Disease.
Najem H; Marisetty A; Horbinski C; Long J; Huse JT; Glitza Oliva IC; Ferguson SD; Kumthekar PU; Wainwright DA; Chen P; Lesniak MS; Burks JK; Heimberger AB
Front Immunol; 2021; 12():745893. PubMed ID: 34691054
[TBL] [Abstract][Full Text] [Related]
33. Follicular programmed death 1-positive lymphocytes in the tumor microenvironment are an independent prognostic factor in follicular lymphoma.
Richendollar BG; Pohlman B; Elson P; Hsi ED
Hum Pathol; 2011 Apr; 42(4):552-7. PubMed ID: 21237493
[TBL] [Abstract][Full Text] [Related]
34. Tumor-infiltrating immune cell profiles and their change after neoadjuvant chemotherapy predict response and prognosis of breast cancer.
García-Martínez E; Gil GL; Benito AC; González-Billalabeitia E; Conesa MA; García García T; García-Garre E; Vicente V; Ayala de la Peña F
Breast Cancer Res; 2014 Nov; 16(6):488. PubMed ID: 25432519
[TBL] [Abstract][Full Text] [Related]
35. Intratumoural-infiltrating CD4 + and FOXP3 + T cells as strong positive predictive markers for the prognosis of resectable colorectal cancer.
Kuwahara T; Hazama S; Suzuki N; Yoshida S; Tomochika S; Nakagami Y; Matsui H; Shindo Y; Kanekiyo S; Tokumitsu Y; Iida M; Tsunedomi R; Takeda S; Yoshino S; Okayama N; Suehiro Y; Yamasaki T; Fujita T; Kawakami Y; Ueno T; Nagano H
Br J Cancer; 2019 Oct; 121(8):659-665. PubMed ID: 31488881
[TBL] [Abstract][Full Text] [Related]
36. The composition of T cell infiltrates varies in primary invasive breast cancer of different molecular subtypes as well as according to tumor size and nodal status.
Glajcar A; Szpor J; Hodorowicz-Zaniewska D; Tyrak KE; Okoń K
Virchows Arch; 2019 Jul; 475(1):13-23. PubMed ID: 31016433
[TBL] [Abstract][Full Text] [Related]
37. Infiltration of CD3⁺ and CD68⁺ cells in bladder cancer is subtype specific and affects the outcome of patients with muscle-invasive tumors.
Sjödahl G; Lövgren K; Lauss M; Chebil G; Patschan O; Gudjonsson S; Månsson W; Fernö M; Leandersson K; Lindgren D; Liedberg F; Höglund M
Urol Oncol; 2014 Aug; 32(6):791-7. PubMed ID: 24794251
[TBL] [Abstract][Full Text] [Related]
38. Clinical impact of immune microenvironment in stage I lung adenocarcinoma: tumor interleukin-12 receptor β2 (IL-12Rβ2), IL-7R, and stromal FoxP3/CD3 ratio are independent predictors of recurrence.
Suzuki K; Kadota K; Sima CS; Nitadori J; Rusch VW; Travis WD; Sadelain M; Adusumilli PS
J Clin Oncol; 2013 Feb; 31(4):490-8. PubMed ID: 23269987
[TBL] [Abstract][Full Text] [Related]
39. Tumor infiltrating immune cells and outcome of Merkel cell carcinoma: a population-based study.
Sihto H; Böhling T; Kavola H; Koljonen V; Salmi M; Jalkanen S; Joensuu H
Clin Cancer Res; 2012 May; 18(10):2872-81. PubMed ID: 22467679
[TBL] [Abstract][Full Text] [Related]
40. Immunophenotypic identification and characterization of tumor cells and infiltrating cell populations in meningiomas.
Domingues PH; Teodósio C; Ortiz J; Sousa P; Otero A; Maillo A; Bárcena P; García-Macias MC; Lopes MC; de Oliveira C; Orfao A; Tabernero MD
Am J Pathol; 2012 Nov; 181(5):1749-61. PubMed ID: 22982440
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]